ANGLE Full Year 2023 Earnings: EPS Misses Expectations
ANGLE (LON:AGL) Full Year 2023 Results
Key Financial Results
Net loss: UK£20.1m (loss narrowed by 7.2% from FY 2022).
UK£0.077 loss per share (improved from UK£0.088 loss in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
ANGLE EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.6%.
Looking ahead, revenue is forecast to grow 47% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Medical Equipment industry in the United Kingdom.
Performance of the British Medical Equipment industry.
The company's shares are down 20% from a week ago.
Risk Analysis
You still need to take note of risks, for example - ANGLE has 5 warning signs (and 1 which makes us a bit uncomfortable) we think you should know about.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.